ADVANCIS PHARMACEUTICAL CORP (AVNC) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 45 transactions totaling $9.2M, demonstrating a bullish sentiment with $8.2M in net insider flow. The most recent transaction on Apr 12, 2007 involved a purchase of 900,000 shares valued at $2.1M.
No significant insider buying has been recorded for AVNC in the recent period.
No significant insider selling has been recorded for AVNC in the recent period.
Based on recent SEC filings, insider sentiment for AVNC is bullish with an Insider Alignment Score of 95/100 and a net flow of $8.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ADVANCIS PHARMACEUTICAL CORP (AVNC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading AVNC stock, having executed 45 transactions in the past 90 days. The most active insider is Mark Leschly (Executive), who has made 1 transactions totaling $2.8M.
Get notified when executives and directors at AVNC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 12, 2007 | R. Werner Harold | Executive | Purchase | 900,000 | $2.36 | $2.1M | Large |
| Apr 12, 2007 | H. Cavanaugh James | Executive | Purchase | 900,000 | $2.36 | $2.1M | Large |
| Apr 12, 2007 | W. Littlechild John | Executive | Purchase | 682,903 | $2.36 | $1.6M | Large |
| Apr 12, 2007 | Leschly Mark | Executive | Purchase | 1,200,000 | $2.36 | $2.8M | Large |
| Nov 21, 2006 | M. Rudnic Edward | Executive | Sale | 2,500 | $4.05 | $10.1K | |
| Nov 21, 2006 | M. Rudnic Edward | Executive | Sale | 700 | $4.10 | $2.9K | |
| Nov 21, 2006 | M. Rudnic Edward | Executive | Sale | 100 | $4.11 | $411 | |
| Nov 21, 2006 | M. Rudnic Edward | Executive | Sale | 1,700 | $4.08 | $6.9K | |
| Nov 21, 2006 | M. Rudnic Edward | Executive | Sale | 5,000 | $4.00 | $20.0K | |
| Nov 10, 2006 | C. Low Robert | Executive | Option Exercise | 20,490 | $1.41 | $28.9K | |
| Sep 20, 2006 | M. Rudnic Edward | Executive | Sale | 300 | $5.66 | $1.7K | |
| Sep 20, 2006 | M. Rudnic Edward | Executive | Sale | 2,800 | $5.65 | $15.8K | |
| Sep 20, 2006 | M. Rudnic Edward | Executive | Sale | 1,200 | $5.62 | $6.7K | |
| Sep 20, 2006 | M. Rudnic Edward | Executive | Sale | 700 | $5.64 | $3.9K | |
| Sep 20, 2006 | M. Rudnic Edward | Executive | Sale | 100 | $5.67 | $567 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 13 | $8.7M | 93.5% |
Sale(S) | 29 | $463.0K | 5.0% |
Exercise(M) | 3 | $143.5K | 1.5% |
Insiders at ADVANCIS PHARMACEUTICAL CORP are accumulating shares at an accelerated pace. With 6 insiders making 45 transactions totaling $8.7M in purchases versus $463.0K in sales, the net buying activity of $8.2M signals strong executive confidence. Mark Leschly (Executive) leads the buying activity with $2.8M in transactions across all time.